Hjem › Brystkreft › New Jersey › Newark
Kliniske studier for Brystkreft i Newark, NJ
18 studier for Brystkreft søker deltakere på steder i og rundt Newark (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruttererFase 3
- Summit Health, Florham Park · 12 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Morristown Medical Center, Morristown · 17 mi unna
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RekruttererFase 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekruttererFase 1/2
- Summit Medical Group, Florham Park · 12 mi unna
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · 9 mi unna
- Summit Medical Group PA, Florham Park · 12 mi unna
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Summit Medical Group, Florham Park · 12 mi unna
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruttererFase 3
- Summit Medical Group, Florham Park · 12 mi unna
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RekruttererObservasjonsstudie
- Summit Medical Group, Florham Park · 12 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
- Morristown Medical Center, Morristown · 17 mi unna
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
RekruttererFase 2
- GSK Investigational Site, Morristown · 17 mi unna
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Morristown Medical Center, Morristown · 17 mi unna
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Rekrutterer
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Morristown Medical Center, Morristown · 17 mi unna
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Rekrutterer
- Summit Health, Florham Park · 12 mi unna
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
RekruttererFase 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · 4 mi unna
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
RekruttererFase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
RekruttererFase 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- og 2 flere
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- Morristown Medical Center, Morristown · 17 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Newark
- Ryggmargsskader13 studier
- Ikke-småcellet lungekreft13 studier
- Akut myelogen leukemi12 studier
- Hjertesvikt10 studier
- Metastatisk kreft10 studier
- Kardiovaskulær sykdom9 studier
- Pankreaskreft9 studier
- Melanom8 studier
- Kreft (alle typer)7 studier
- Lungekreft7 studier
- Crohns sykdom7 studier
- Stenose i aortaklaffen6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.